377 related articles for article (PubMed ID: 30065221)
1. Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.
Sathisaran I; Dalvi SV
Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 30065221
[TBL] [Abstract][Full Text] [Related]
2. Diffusion and Flux Improvement of Drugs through Complexation.
Mannava MKC; Garai A; Nangia AK
Mol Pharm; 2023 May; 20(5):2293-2316. PubMed ID: 36974968
[TBL] [Abstract][Full Text] [Related]
3. Dissolution Enhancement of Atorvastatin Calcium by Cocrystallization.
Al-Kazemi R; Al-Basarah Y; Nada A
Adv Pharm Bull; 2019 Oct; 9(4):559-570. PubMed ID: 31857959
[No Abstract] [Full Text] [Related]
4. Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development.
Gadade DD; Pekamwar SS
Adv Pharm Bull; 2016 Dec; 6(4):479-494. PubMed ID: 28101455
[TBL] [Abstract][Full Text] [Related]
5. Isostructural cocrystals of metaxalone with improved dissolution characteristics.
Gohel SK; Palanisamy V; Sanphui P; Prakash M; Singh GP; Chernyshev V
RSC Adv; 2021 Sep; 11(49):30689-30700. PubMed ID: 35479860
[TBL] [Abstract][Full Text] [Related]
6. Recent Advancements in Pharmaceutical Cocrystals, Preparation Methods, and their Applications.
Manchanda D; Kumar A; Nanda A
Curr Pharm Des; 2021; 27(44):4477-4495. PubMed ID: 33858309
[TBL] [Abstract][Full Text] [Related]
7. Obtaining Cocrystals by Reaction Crystallization Method: Pharmaceutical Applications.
Biscaia IFB; Gomes SN; Bernardi LS; Oliveira PR
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34204318
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in improving oral drug bioavailability by cocrystals.
Emami S; Siahi-Shadbad M; Adibkia K; Barzegar-Jalali M
Bioimpacts; 2018; 8(4):305-320. PubMed ID: 30397585
[No Abstract] [Full Text] [Related]
9. Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.
Newman A; Reutzel-Edens SM; Zografi G
J Pharm Sci; 2018 Jan; 107(1):5-17. PubMed ID: 28989014
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical cocrystals and poorly soluble drugs.
Thakuria R; Delori A; Jones W; Lipert MP; Roy L; Rodríguez-Hornedo N
Int J Pharm; 2013 Aug; 453(1):101-25. PubMed ID: 23207015
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.
Panzade P; Shendarkar G; Shaikh S; Balmukund Rathi P
Adv Pharm Bull; 2017 Sep; 7(3):399-408. PubMed ID: 29071222
[No Abstract] [Full Text] [Related]
12. The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals.
Ren S; Liu M; Hong C; Li G; Sun J; Wang J; Zhang L; Xie Y
Acta Pharm Sin B; 2019 Jan; 9(1):59-73. PubMed ID: 30766778
[TBL] [Abstract][Full Text] [Related]
13. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.
Nijhawan M; Santhosh A; Babu PR; Subrahmanyam CV
Drug Dev Ind Pharm; 2014 Sep; 40(9):1163-72. PubMed ID: 23829186
[TBL] [Abstract][Full Text] [Related]
14. Experimental cocrystal screening and solution based scale-up cocrystallization methods.
Malamatari M; Ross SA; Douroumis D; Velaga SP
Adv Drug Deliv Rev; 2017 Aug; 117():162-177. PubMed ID: 28811184
[TBL] [Abstract][Full Text] [Related]
15. Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer.
Yamashita H; Sun CC
Pharm Res; 2017 Dec; 35(1):4. PubMed ID: 29288433
[TBL] [Abstract][Full Text] [Related]
16. Cocrystals, Salts, and Salt-Solvates of olanzapine; selection of coformers and improved solubility.
Gong W; Mondal PK; Ahmadi S; Wu Y; Rohani S
Int J Pharm; 2021 Oct; 608():121063. PubMed ID: 34481007
[TBL] [Abstract][Full Text] [Related]
17. Vibrational Spectroscopy for Cocrystals Screening. A Comparative Study.
Rodrigues M; Lopes J; Sarraguça M
Molecules; 2018 Dec; 23(12):. PubMed ID: 30544751
[TBL] [Abstract][Full Text] [Related]
18. Superior Solubility and Dissolution of Zaltoprofen via Pharmaceutical Cocrystals.
Panzade P; Shendarkar G
Turk J Pharm Sci; 2019 Sep; 16(3):310-316. PubMed ID: 32454729
[TBL] [Abstract][Full Text] [Related]
19. Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems.
Singh M; Barua H; Jyothi VGSS; Dhondale MR; Nambiar AG; Agrawal AK; Kumar P; Shastri NR; Kumar D
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111646
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics.
Bhalani DV; Nutan B; Kumar A; Singh Chandel AK
Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
